Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation
Peter A. Riedell
, Mehdi Hamadani
, Kwang W. Ahn
, Carlos Litovich
, Claudio G. Brunstein
, Amanda F. Cashen
, Jonathon B. Cohen
, Narendranath Epperla
, Brian T. Hill
, Annie Im
, David J. Inwards
, John Lister
, John M. McCarty
, Sai Ravi Kiran Pingali
, Mazyar Shadman
, Paul Shaughnessy
, Melhem Solh
, Patrick J. Stiff
, Julie M. Vose
, Mohamed A. Kharfan-Dabaja
Alex F. Herrera, Craig S. Sauter, Sonali M. Smith
Show 3 others
Show less
Medicine - Hematology, Oncology, Transplant
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Time Effect
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Mantle Cell Lymphoma
100%
Overall Survival
100%
Time to Relapse
100%
Hazard Ratio
50%
Early Relapse
33%
Novel Therapeutics
16%
High-risk Population
16%
Lymphoma
16%
Induction Therapy
16%
Standard of Care
16%
Multivariate Analysis
16%
Retrospective Analysis
16%
Well-defined
16%
Risk Assessment Tool
16%
Time Impact
16%
Lymphoma Patients
16%
Marrow Transplantation
16%
Lymphoma Diagnosis
16%
Time-to-event Analysis
16%
Transplanting Time
16%
Landmark Model
16%
Medicine and Dentistry
Hematopoietic Cell
100%
Mantle Cell Lymphoma
100%
Cell Transplantation
100%
Overall Survival
100%
Hazard Ratio
50%
High Risk Population
16%
Multivariate Analysis
16%